RSS

NRXP NRx Pharmaceuticals Inc.

Mod: trooperstocks
Last Post: 04/22/26
Followers: 1
Posts Today: 0
Views Today: 16

NRXP Stock Quote & Tools

$2.9800 ▲ +0.0700 (+2.41%) As of Apr 30, 4:00 PM EDT
Last2.9800
$ Chg0.0700
Open2.9200
High3.0700
Beta1.7986
Year High3.840
Market Cap98.54M
P/B Ratio-6.12
EPS-1.34
Avg Vol (30d)1.04M
Volume957.8K
% Chg+2.41%
Prev Close2.9100
Low2.8800
VWAP2.99243
Year Low1.620
Total Shares33.07M
Shares Out33.07M
Float28.04M
ExchangeNCM
Healthcare Biotechnology & Life Sciences
Company Profile Buy Rating Time & Sales News Filings Financials

NRXP Stock Message Board Discussion

1 Pinned Post
$NRXP News: NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief (1) by trooperstocks
  1. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives Positive FDA Review Letter

  2. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Supports Executive Order To

  3. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms NRx Defense Systems

  4. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Appoints First Chief Commercial

  5. NetworkNewsWire

    NetworkNewsBreaks InvestorNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA

  6. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Files 2025 Form 10-K And Highlights

  7. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Feedback On

  8. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Guidance Supporting

  9. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Guidance Supporting

  10. NetworkNewsWire

    NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Appoints TMS, Neuroplasticity Researcher Joshua Brown

  11. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Opens

  12. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Appoints Prof. Joshua C. Brown As

  13. trooperstocks

    $NRXP News: NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief

    (1)
  14. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Completes FDA Type C Meeting for

  15. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Licenses Real-World Evidence From

  16. Lee Adams

    $NRXP News: NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of

  17. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Eliminates Balance Sheet Debt

  18. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Amends IND to Advance NRX-101 With

  19. trooperstocks

    $NRXP News: NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of

  20. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Schedules Corporate Update Call for

  21. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announces FDA Receipt of ANDA for

  22. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Present at NobleCon21 NRx

  23. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Reports Q3 Results and Advances

  24. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Q3 2025 Financial Results

  25. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Launches HOPE Therapeutics

  26. NetworkNewsWire

    NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Pursues Dual Pathway for Preservative-Free

  27. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Advances KETAFREE(TM), Expands

  28. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Present at Noble Capital Markets

  29. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Re-files ANDA for Preservative-Free

  30. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Approval of

  31. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Closes

  32. Lee Adams

    $NRXP News: HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the

  33. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Join H.C. Wainwrights 27th

  34. NetworkNewsWire

    NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Secures FDA Fast Track for IV Ketamine Formulation

  35. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Showcases HOPE Therapeutics at

  36. Lee Adams

    $NRXP UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global

  37. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announces Expanded Access Policy

  38. Lee Adams

    $NRXP News: NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100

  39. NetworkNewsWire

    NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative -

  40. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Reports Q2 2025 Results, Highlights

  41. Lee Adams

    NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on

  42. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Fast Track Designation

  43. Lee Adams

    $NRXP News: NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Granted FDA Fast Track Designation for NRX-100

  44. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics(TM)

  45. Lee Adams

    $NRXP News: HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Receipt

  46. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Petitions FDA to Ban Benzethonium

  47. Lee Adams

    $NRXP News: NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of a Citizen Petition with

  48. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) CEO to Join Fireside Chat at BTIG

  49. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Charts Dual-Path for NRX-100

  50. NetworkNewsWire

    NetworkNewsBreaks NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Positioning at the Forefront of